Safety of aclidinium bromide/formoterol fumarate fixed dose combination (FDC) in COPD: Pooled analyses of three phase III studies

ConclusionsOverall, the safety profile of FDC BID was comparable with placebo and with the individual monotherapies.

Source: European Respiratory Journal - December 23, 2014 Category: Respiratory Medicine Authors: Korn, S., Kerwin, E., Donohue, J. F., Shrestha, P., Leselbaum, A., Lei, A. Tags: 5.1 Airway Pharmacology and Treatment Source Type: research